Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Bicycle Therapeutics Q1 2024 GAAP EPS $(0.62) Beats $(1.31) Estimate, Sales $19.530M Beat $6.029M Estimate

Author: Benzinga Newsdesk | May 02, 2024 07:53am

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(1.31) by 52.67 percent. This is a 52.31 percent increase over losses of $(1.30) per share from the same period last year. The company reported quarterly sales of $19.530 million which beat the analyst consensus estimate of $6.029 million by 223.91 percent. This is a 298.90 percent increase over sales of $4.896 million the same period last year.

Posted In: BCYC